HOLX vs JNJ · P/E 32, rev $4.10B vs P/E 17, rev $49.37B
Hologic Inc (HOLX) versus Johnson & Johnson (JNJ) — a side-by-side from cached financials, not a winner call.
Hologic Inc (HOLX) is a medical instruments & supplies company listed on NASDAQ.
Johnson & Johnson (JNJ) is a drug manufacturers - general company listed on US. It is led by Joaquin Duato.
Latest reported HOLX revenue for 2025-09-27 was $4.10B. Net income was $565.7M. Revenue was up 1.7% from 2024-09-28 to 2025-09-27. HOLX currently screens at market cap $16.97B and trailing P/E 31.5.
Latest reported JNJ revenue for 2026-06-28 was $49.37B. Net income was $10.77B. JNJ currently screens at market cap $375.37B and trailing P/E 17.4.
HOLX currently screens at market cap $16.97B and trailing P/E 31.5. JNJ currently screens at market cap $375.37B and trailing P/E 17.4.
Not investment advice. Open the HOLX and JNJ stock pages for the full models.
Not investment advice.